Anonymous
Guest
Anonymous
Guest
To the few people who are doing great with this sorry drug, congratulations. A few are doing remarkably well, what with relationships and a territory that allows you to actually see providers, and whatever else it is that helps you get the job done. It does ultimately come down to personal responsibility.
To you self-righteous prigs who are saying that we "didn't get off our lazy ass", you can bash those who left all you want. There are a variety of reasons that these people are gone. (I counted 44, average age 45 years. And that's just the first wave. The PIPs and other resignations are yet to come.) Greatest among them is the failure of a company, that is supposedly savvy in the pain space, to see any of this coming. They must have talked to at least a few prescribers that said this drug is a dog.
I believed what happened after that will become history for this company. Mallinckrodt has done well, having survived for nearly 150 years. The multitude of bad decisions that have been made in the last 15 years may prove fatal.
When Mallinckrodt decided to put together a brand sales organization, that was the beginning of the end. There has never been, and is not now, a management team in place at Mallinckrodt, that knows how to run a sales and marketing organization. There have been many iterations of that team.
And I truly believe that, what's happening now, is the paring down of that organization--reducing overhead, getting lean and mean, call it what you want--in preparation for some form of M&A. Mallinckrodt is for sale!
Bringing on Cadence and Questcor just added to the market cap, so that a potential buyer with deeper pockets would be interested. Remember the 20% rule. The Dublin HQ is a big carrot to be had before 20% goes to 50%. The bill is already in Congress.
MNK 155 will be an "asset" in that transaction. It will not be launched by this team in its (the team's) present form. Mallinckrodt does not want ANOTHER disaster. 155 will be a CII when it's launched.
And don't forget what usually happens to the sales team of the prey. 80+% are usually gone. It appears to already be underway.
Be wise. Make good decisions. If you're not part of the 90% or so that are looking, think about it.
God bless us all.
To you self-righteous prigs who are saying that we "didn't get off our lazy ass", you can bash those who left all you want. There are a variety of reasons that these people are gone. (I counted 44, average age 45 years. And that's just the first wave. The PIPs and other resignations are yet to come.) Greatest among them is the failure of a company, that is supposedly savvy in the pain space, to see any of this coming. They must have talked to at least a few prescribers that said this drug is a dog.
I believed what happened after that will become history for this company. Mallinckrodt has done well, having survived for nearly 150 years. The multitude of bad decisions that have been made in the last 15 years may prove fatal.
When Mallinckrodt decided to put together a brand sales organization, that was the beginning of the end. There has never been, and is not now, a management team in place at Mallinckrodt, that knows how to run a sales and marketing organization. There have been many iterations of that team.
And I truly believe that, what's happening now, is the paring down of that organization--reducing overhead, getting lean and mean, call it what you want--in preparation for some form of M&A. Mallinckrodt is for sale!
Bringing on Cadence and Questcor just added to the market cap, so that a potential buyer with deeper pockets would be interested. Remember the 20% rule. The Dublin HQ is a big carrot to be had before 20% goes to 50%. The bill is already in Congress.
MNK 155 will be an "asset" in that transaction. It will not be launched by this team in its (the team's) present form. Mallinckrodt does not want ANOTHER disaster. 155 will be a CII when it's launched.
And don't forget what usually happens to the sales team of the prey. 80+% are usually gone. It appears to already be underway.
Be wise. Make good decisions. If you're not part of the 90% or so that are looking, think about it.
God bless us all.